home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

213 rows where filing_period = "third_quarter", filing_year = 2009 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 213 ✖

filing_year 1

  • 2009 · 213 ✖

filing_period 1

  • third_quarter · 213 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
743680 RUBICON ADVISORS, LLC 9d7e8c3d-2b56-4810-8499-012c982b3214 3A RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 third_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-02-10T20:06:50-05:00
821512 HOLLAND & KNIGHT LLP 2f2d1d9a-75bb-4ac7-9832-108c47712a34 Q3 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2009 third_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2009-09-30T10:29:59-04:00
821521 HOLLAND & KNIGHT LLP c495c6b4-a622-49c0-af64-2882c39edcd3 Q3 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2009 third_quarter PHA Blood and blood product safety; issues related to blood product approvals. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2009-09-30T10:35:03-04:00
821880 MR. THEODORE (TED) JONES 2cdcbfdc-f0a8-455c-a4a8-26e900172402 Q3 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2009 third_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-10-01T16:34:10-04:00
821994 CYBER SECURITY RESEARCH CONSULTANTS, LLC 420eac77-49c2-416f-92d5-e5113924d8a5 Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2009 third_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe drug reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-10-02T11:44:50-04:00
823140 CAPITOL HILL CONSULTING GROUP 1d74c4ba-4d6c-49ed-a999-f3b1aba33c39 Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2009 third_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-10-06T17:00:18-04:00
823358 HOLLAND & KNIGHT LLP d258e831-787a-4758-b149-d5ecacde2351 Q3 HOLLAND & KNIGHT LLP 18466 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2009 third_quarter PHA Issues relating to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2009-10-07T12:25:00-04:00
823802 PARRY, ROMANI, DECONCINI & SYMMS 87561aaa-14ef-47ee-b926-239058546a67 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AMERICAN ASSOCIATION FOR HEALTH FREEDOM 2009 third_quarter PHA Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-08T11:50:32-04:00
823947 DUTKO WORLDWIDE, LLC b4bae6fb-4567-470c-b05d-fbd516b47e1b Q3 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2009 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-08T14:32:39-04:00
823962 PARRY, ROMANI, DECONCINI & SYMMS 2c980906-f1b1-4b95-9af7-498b9ace3fda Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2009 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-10-08T14:36:46-04:00
824062 PARRY, ROMANI, DECONCINI & SYMMS c525d7dd-39e5-4261-9dc4-7225397e0f60 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2009 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-10-08T15:57:38-04:00
824107 PARRY, ROMANI, DECONCINI & SYMMS e8fb36fb-6cb0-46a4-8180-c308fcccba84 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2009 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-10-08T16:47:58-04:00
824112 PARRY, ROMANI, DECONCINI & SYMMS dad52946-3a8c-420c-a11f-5da434cc1b23 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2009 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-10-08T16:55:01-04:00
824340 JULIE PHILP 939ecf5f-486d-43d7-9d8a-f485b851f9eb Q3 JULIE PHILP 400407928 NATIONAL GRASSROOTS AND COMMUNICATION 2009 third_quarter PHA Medicare and Medicaid issues; HR 1204, an antitrust examption for independent pharmacists to negotiate with private insurers and pharmacy benefit managers; HR 3200, to incluse pharmacy provisions to increase generic utilization of medications, provide for pharmacy benefit manager transparency, and increase dispensing fees for pharmacies. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-10-09T11:30:23-04:00
824661 AMERICAN COLLEGE OF CLINICAL PHARMACY ad242758-dc5a-47bd-b1d1-9bb4e8eeb672 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2009 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare Part B and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59700 0 0 2009-10-09T16:17:00-04:00
825315 SQUIRE PATTON BOGGS 1f6d5ecf-5d79-4945-8f66-885572b8019d Q3 SQUIRE PATTON BOGGS 30906 KERR CORPORATION 2009 third_quarter PHA Issues related to FDA enforcement action against counterfeits of client's medical devices. HOUSE OF REPRESENTATIVES     0 0 2009-10-13T08:38:01-04:00
825416 INDEPENDENT PHARMACY COOPERATIVE 8504e48a-07bd-46c1-b577-578696c9dad1 Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2009 third_quarter PHA H.R. 3200 America's Affordable Health Choices Act of 2009. DMEPOS exemption and Average Manufacturer Price FULprovisions for pharmacy. Senate Finance Health Reform draft legislation. DMEPOS exemption and Average Manufacturer Price FUL provisions for pharmacy. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2009-10-13T10:35:04-04:00
825429 POLICY DIRECTIONS INC. e4ff8646-97c7-4260-9646-8d26449c96c0 Q3 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2009 third_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-10-13T10:40:14-04:00
825853 GREATER NEW YORK HOSPITAL ASSOCIATION 9c9099ce-348a-4e9c-b3ff-f87e311812d1 Q3 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2009 third_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); America's Healthy Futures Act (Senate Finance Committee bill); House Tri-Committee bill (H.R. 3200); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239)) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,White House Office   370000 0 0 2009-10-13T14:14:14-04:00
825917 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) d525b4f4-bc20-4a83-aea9-92df9bbed714 Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2009 third_quarter PHA Importation of prescription drugs (S. 525/S. 1232/H.R. 1298) Rx Pedigree Pharmacy Accreditation Delay (H.R. 3663) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2009-10-13T14:33:38-04:00
826148 FIERCE, ISAKOWITZ & BLALOCK b6b47a79-eaac-4ef6-86da-6a18f00f3fab Q3 FIERCE, ISAKOWITZ & BLALOCK 44812 MOMENTA PHARMACEUTICALS, INC. 2009 third_quarter PHA Generic Biologics: -S726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act -H.R.1548: Pathway for Biosimilars Act -S.1679 Affordable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE,White House Office 20000   0 0 2009-10-13T15:41:41-04:00
826649 MEREDITH MCGEHEE a41898a4-cf64-4871-8132-d8e01307166d Q3 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2009 third_quarter PHA Funding for programs to develop AIDS vaccines targeted toward the developing world; Educating about research and development programs aimed at the AIDS epidemic; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on Protocol G work and "The Antibody Project"; Role of FDA in vaccines for developing world HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-10-14T10:27:16-04:00
827417 VENABLE LLP 450e023c-bcb4-4269-92a1-0b3a602a35b6 Q3 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2009 third_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-10-14T15:56:21-04:00
827624 THE UNITED STATES PHARMACOPEIAL CONVENTION c617db9d-33e8-473b-bc21-03a88467d2cc Q3 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2009 third_quarter PHA - HR 1859, "Independent Drug Education & Outreach Act", regarding all provisions as a neutral, expert scientific resource. - S 726, "Promoting Innovation and Access to Lifesaving Medicine Act, regarding all provisions. - Issues relating to heparin. - Information regarding USP General Chapter <1> Injections - labeling on ferrules and cap overseals, specifically to update Congress on USP standards. - Information on follow-on biologics. - Information on drug quality as a neutral, expert scientific resource. Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   90000 0 0 2009-10-14T16:57:17-04:00
827802 PRO UNLIMITED 9b5913da-151a-4073-aa95-55b32e268281 Q3 PRO UNLIMITED 400412954 SANOFI-AVENTIS U S INC 2009 third_quarter PHA Manufacturing pricing or rebate obligations for heath benefits related to pharmaceuticals; Medicare, Medicaid and veterans administration and public health service programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-10-14T18:14:43-04:00
827839 WINBORN SOLUTIONS LLC cafd10a3-00f6-4d0f-9d35-550932732dcc Q3 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2009 third_quarter PHA Dextromethorphan Distribution Act of 2009 Food and drug safety, user fee and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2009-10-14T19:27:11-04:00
828121 VAN SCOYOC ASSOCIATES 6db6180a-4b79-4a18-8017-0f6c11d50ba9 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2009 third_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) 40000   0 0 2009-10-15T09:18:02-04:00
828131 VAN SCOYOC ASSOCIATES 4898e28f-6c35-4c58-8263-af9aad76517d Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2009 third_quarter PHA H.R.2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-15T09:20:05-04:00
828146 VAN SCOYOC ASSOCIATES 6f1a5f34-a555-454d-917f-229ba8d4902d Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2009 third_quarter PHA H.R.2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-10-15T09:22:07-04:00
828890 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS df2be76a-ebde-4ad5-8126-b9dcb7389619 Q3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2009 third_quarter PHA Meeting with FDA relating to removal of unapproved products, opportunities for future collaboration; Risk Evaluation and Mitigation Strategies. Meeting with FDA regarding design and use of NDC number. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   250000 0 0 2009-10-15T12:33:24-04:00
829397 PARRY, ROMANI, DECONCINI & SYMMS 81d8d2fa-8795-44b4-be24-b5cd59bd9628 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2009 third_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2009-10-15T14:50:09-04:00
829464 BROWN RUDNICK LLP dc133446-cd5e-44c0-8bf5-2781f364f1d4 Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2009 third_quarter PHA S.525 & H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-15T15:01:18-04:00
829899 FABIANI & COMPANY 45dc20bf-bde5-45f7-8fac-2fdf490d38a2 Q3 FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2009 third_quarter PHA Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-15T16:48:05-04:00
829930 FABIANI & COMPANY aa6841b4-57da-4a67-89a8-e6745d288c67 3A FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2009 third_quarter PHA Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-15T17:02:19-04:00
829971 FLYNN & ASSOCIATES, INC. fae010af-97cc-4704-8847-5556bb00ee89 Q3 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2009 third_quarter PHA Patent Life Issues Healthcare Reform Pharmaceutical industry employment issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-10-15T17:14:42-04:00
830878 MASSACHUSETTS MEDICAL SOCIETY 0ca4c715-ae9b-4540-a1ce-fcd359afd7a8 Q3 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2009 third_quarter PHA S. 301, Physician Payment Sunshine Act legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians HOUSE OF REPRESENTATIVES,SENATE,White House Office   80000 0 0 2009-10-16T10:43:26-04:00
831403 NATIONAL ASSOCIATION OF CHAIN DRUG STORES fc9322bc-91ea-49c6-ba1e-2df7a9645284 Q3 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2009 third_quarter PHA H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. … Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office   720000 0 0 2009-10-16T11:44:40-04:00
831817 BUCHANAN INGERSOLL & ROONEY PC 4c113b4c-2d8e-4baf-b1d3-0fd2cf15699e Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 AVI BIOPHARMA, INC. 2009 third_quarter PHA Biodefense funding issues in the US House, US Senate and other agencies. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-16T12:35:14-04:00
831829 BUCHANAN INGERSOLL & ROONEY PC 335dea9c-f3cd-4324-838f-10305281910e Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 BIOFACTURA 2009 third_quarter PHA Biotechnology, Disaster Planning, Homeland Security, Science & Technology and Pharmacy issues with the US House, US Senate and Federal Agencies Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-16T12:36:17-04:00
831870 AMYLIN PHARMACEUTICALS 9a85cbf6-6738-45e5-9e11-452a51fbe7bd Q3 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2009 third_quarter PHA Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009 FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   330000 0 0 2009-10-16T12:45:25-04:00
831888 EISAI INC. 0ca271c1-62e4-45b3-9e9b-5024186ca08c Q3 EISAI INC. 400321512 EISAI INC. 2009 third_quarter PHA Establishment of pathway for the approval of biosimilars in health reform legislation HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 369, Preserve Acess to Affordable Generics Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE   810000 0 0 2009-10-16T12:47:59-04:00
831973 EXPRESS SCRIPTS, INC. 912146cc-02aa-4f50-baa7-0527ebc03490 Q3 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2009 third_quarter PHA Items related to reverse settlement payments between manufacturers--HR 1706, S. 369 Items related to oversight of the federal employees health benefits program and its pharmacy benefit Design and coverage of pharmacy benefits in new Health Exchanges/Gateways as well as pharmacy benefit managers transparency requirements--America's Healthy Future Act, S. 1679, HR 3200 Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2009-10-16T13:02:53-04:00
832504 BUCHANAN INGERSOLL & ROONEY PC dfdf7c1e-1cca-43b6-af4f-1cf0eadf2e34 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 IPEC - AMERICAS, INC. 2009 third_quarter PHA FDA Globalization Acts and legislation related to supply chain security and drug contaminations issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-16T14:41:09-04:00
832843 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 11650e1f-230b-4091-8df1-3802657c2c98 Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2009 third_quarter PHA H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 100th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; (more) Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements and small business tax provisions; H.R. 1166 (E-Fencing Enforcement Act of 2009), H.R. 1173 (Organized Retail Crime Act of 2009) and S. 470 (Combating Organized Retail Crime Act of 2009); H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009; S. 1383, the "Dextromethorphan Abuse Reduction Act; and "H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and requirements for businesses to provide health insurance, and pharmacy benefit manager transparency requirements. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE   180000 0 0 2009-10-16T15:22:29-04:00
833293 BUCHANAN INGERSOLL & ROONEY PC 5b3b49c0-0e52-481f-8f22-21af8deff17a Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 SHIRE PHARMACEUTICALS INC 2009 third_quarter PHA Pathway for follow-on biologics; orphan drugs, healthcare reform; DEA quota. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-16T16:38:20-04:00
833357 JOHNS HOPKINS UNIVERSITY cd515b3c-8538-42ed-9c12-cde1f6f8a5c4 Q3 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2009 third_quarter PHA H.R. 444, 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting. HOUSE OF REPRESENTATIVES,SENATE   220000 0 0 2009-10-16T16:48:23-04:00
833512 BUCHANAN INGERSOLL & ROONEY PC dbaffbb9-92ce-49d9-ae93-adc47992fe5c Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 XOMA 2009 third_quarter PHA Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate. Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 20000   0 0 2009-10-16T17:20:41-04:00
833726 US STRATEGIES 3b015271-ad7a-443a-a527-8779b56eb980 Q3 US STRATEGIES 38825 NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) 2009 third_quarter PHA Medicare and Medicaid provisions relating to pharmacy and medication management policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-10-16T18:33:26-04:00
833983 PODESTA GROUP, INC. c0262eca-a278-4730-8d4f-6d1722053747 Q3 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2009 third_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-17T16:18:32-04:00
833990 PODESTA GROUP, INC. 7d5c09a3-3698-4625-a928-ea4f5f90bf49 Q3 PODESTA GROUP, INC. 31680 CUBIST PHARMACEUTICALS INC 2009 third_quarter PHA Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act S. 369 Preserve Access to Affordable Generics Act of 2009 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2009-10-17T16:19:34-04:00
833993 PODESTA GROUP, INC. a6364324-7555-4aa1-a652-55975f959788 Q3 PODESTA GROUP, INC. 31680 EISAI INC. 2009 third_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 369 Preserve Access to Affordable Generics Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-17T16:20:36-04:00
833996 PODESTA GROUP, INC. 7d9a85b7-6054-4edf-97fc-e1666b82275a Q3 PODESTA GROUP, INC. 31680 EMD SERONO INC 2009 third_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 60000   0 0 2009-10-17T16:21:38-04:00
834004 PODESTA GROUP, INC. 591314ee-3b53-4971-ba09-04e19c3c1220 Q3 PODESTA GROUP, INC. 31680 WINNING STRATEGIES WASHINGTON LLC 2009 third_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy American Health Choices Act of 2009 H.R. 3200 American Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 H.R. 616 Pharmacists Exemption to CMS DME Requirements Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-17T16:23:48-04:00
834262 TARPLIN STRATEGIES LLC 4a3a28e4-bd91-4681-b34b-71e59ad2806b Q3 TARPLIN STRATEGIES LLC 40032282 GENENTECH, INC. 2009 third_quarter PHA H.R. 1548, the Pathway for Biosimilars Act, FDA approval of follow-on biologics. H.R. 1427 and S. 726, the Promoting Innovation and Access to Life-Saving Medicine Act, FDA approval of follow-on biologics. H.R. 3200, America's Affordable Health Choices Act - FDA approval of follow-on biologics and length of data exclusivity period. S. 1679, the Affordable Health Choices Act - FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program. Senate Finance Committee Chairman's Mark, America's Healthy Future Act - Medicare and Medicaid reimbursement issues, possible taxes and fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. S. 1232, the Pharmaceutical Market Access and Drug Safety Act, importation of prescription drugs. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2009-10-18T15:40:26-04:00
834376 FIERCE, ISAKOWITZ & BLALOCK 5f91dc15-fdf6-447f-bfbd-f8fac7f7f283 Q3 FIERCE, ISAKOWITZ & BLALOCK 44812 COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET 2009 third_quarter PHA Generic Biologics: -S726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act -H.R.1548: Pathway for Biosimilars Act -S.1679 Affordable Health Choices Act Americas Health Future Act of 2009 -Biosimilar Reimbursement Utilization Equity Amendment -Limited Exception to Anti-Kickback Statute to Waive Co-payments For Generic Drugs HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-18T18:50:55-04:00
834503 POLICY ADVOCATES 703b63a4-41a5-4e3d-ab98-ccf797df2846 Q3 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2009 third_quarter PHA Track and monitor Internet Pharmacy Issues. HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2009-10-19T07:25:44-04:00
834612 INDEPENDENCE BLUE CROSS f28690fa-d36c-4580-8ab0-d6d1cc18e6c3 Q3 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2009 third_quarter PHA Restructuring FEHBP Rx benefits Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office     0 0 2009-10-19T09:05:32-04:00
834701 AMERICAN VETERINARY MEDICAL ASSOCIATION d9235a8e-5a2e-44a5-b915-9bf75c48fb8a Q3 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2009 third_quarter PHA H.R. 1549/S. 619, Preservation of Antibiotics for Medical Use Act Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2009-10-19T09:27:01-04:00
834747 UNIVERSITY OF CONNECTICUT 743bebb4-d30d-488a-b1f1-a04b4a180dcd Q3 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2009 third_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)   70000 0 0 2009-10-19T09:35:07-04:00
834796 U.S. CHAMBER INSTITUTE FOR LEGAL REFORM 4ae8657f-5a0c-48a4-b643-e4ab3f3eeb3b Q3 U.S. CHAMBER INSTITUTE FOR LEGAL REFORM 51172 U S CHAMBER INSTITUTE FOR LEGAL REFORM 2009 third_quarter PHA S. 540/H.R. 1346, Medical Device Safety Act of 2009 General background on drug and device labeling rules and the doctrine of Federal preemption (no specific legislation introduced) HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Securities & Exchange Commission (SEC),SENATE   4240000 0 0 2009-10-19T09:39:30-04:00
834901 APTIV, PLC ac207965-6e00-4d99-a74d-6a49ac7a8fff Q3 APTIV, PLC 49054 APTIV PLC 2009 third_quarter PHA No activity this quarter Energy, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Pension Benefit Guaranty Corporation (PBGC),SENATE,Transportation Security Administration (TSA)   190000 0 0 2009-10-19T09:51:56-04:00
834999 CHAMBER OF COMMERCE OF THE U.S.A. 102e20ba-30c8-4c21-b276-cef0795b7d8c Q3 CHAMBER OF COMMERCE OF THE U.S.A. 38756 CHAMBER OF COMMERCE OF THE U.S.A. 2009 third_quarter PHA H.R. 1346/S. 540, Medical Device Safety Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act of 2009 (Bill number not yet available) Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Accounting Standards Advisory Board (FASAB),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Labor Relations Board (NLRB),Natl Mediation Board,Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Fish & Wildlife Service (USFWS),U.S. Trade Representative (USTR),White House Office   34690000 0 0 2009-10-19T10:02:22-04:00
835340 KIRKLAND & ELLIS LLP c19c0300-0084-4cd7-b356-4de5771d9054 Q3 KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2009 third_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-19T10:35:27-04:00
835549 MOFFETT GROUP, LLC 563c852f-f203-4ed1-8a51-f416eadea87d Q3 MOFFETT GROUP, LLC 82578 BOEHRINGER INGELHEIM PHARMECEUTICAL 2009 third_quarter PHA Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. Our work is specifically related to the Connecticut delegation. HOUSE OF REPRESENTATIVES,SENATE 51293   0 0 2009-10-19T10:50:39-04:00
835751 WINNING STRATEGIES WASHINGTON ad00a43b-03d8-4d89-8d44-c1b2b9c62544 Q3 WINNING STRATEGIES WASHINGTON 50796 DIABETES ACCESS TO CARE COALITION (DACC) 2009 third_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-19T11:06:21-04:00
836403 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM fc012bf3-9811-4fa6-a465-4043e60629be Q3 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2009 third_quarter PHA HR 444, 3200; S1239, Senate Finance Committee To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers; any language expanding 340B drug discounts to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   47778 0 0 2009-10-19T11:52:24-04:00
836540 MEHLMAN CONSULTING, INC. 809a92eb-daba-48ea-9562-db013b8aaf66 Q3 MEHLMAN CONSULTING, INC. 284950 ABBOTT LABORATORIES 2009 third_quarter PHA Health care reform: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choice Act. Food & Drug Administration reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-19T12:00:01-04:00
836865 TWENTY-FIRST CENTURY GROUP, INC. 5d9c643f-dbf5-43ba-96c4-b5ec165fd3d0 Q3 TWENTY-FIRST CENTURY GROUP, INC. 38687 SCHERING-PLOUGH 2009 third_quarter PHA General pharmaceutical issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-19T12:24:02-04:00
836971 ASSOCIATION FOR ACCESSIBLE MEDICINES 7b533b71-936d-47a6-a6ce-67e6c0dbd5ea Q3 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2009 third_quarter PHA Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office   508363 0 0 2009-10-19T12:36:34-04:00
837933 BUCHANAN INGERSOLL & ROONEY PC 147dad37-5b30-40a3-bbbc-886deaa727f6 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2009 third_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-19T14:04:30-04:00
838113 GILBERT'S LLP 80cc479f-de05-426d-be75-841f730f4747 Q3 GILBERT'S LLP 67876 MYLAN LABORATORIES INC 2009 third_quarter PHA Reform to legislation and regulations affecting pharmaceutical drug approval and marketing Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2009-10-19T14:19:01-04:00
838189 THE KROGER CO. 53f8cc6b-e79a-4f47-a0ca-b09b8140bbe1 Q3 THE KROGER CO. 88212 KROGER CO 2009 third_quarter PHA S. 511 Access to Durable Medical Equipment Act HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2009-10-19T14:24:21-04:00
838421 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION d37380b5-c162-4d9d-b206-8aae7280faaa Q3 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2009 third_quarter PHA Items related to the application of drug benefits to public plans and health exchange, including PBM disclosure, in HR 3200, S 1679 Americas Health Future Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   325548 0 0 2009-10-19T14:38:25-04:00
838681 OGR ce3ffaae-01de-405f-b2a3-f9be5eb3c130 Q3 OGR 48827 SANOFI PASTEUR 2009 third_quarter PHA vaccine related issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-19T14:56:15-04:00
838702 FOLEY & LARDNER LLP b891b0ae-77e2-4e78-9129-642f7e7618ab Q3 FOLEY & LARDNER LLP 15042 UNITED THERAPEUTICS 2009 third_quarter PHA Approval and funding for development and application of broad spectrum antiviral drugs HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-19T14:58:16-04:00
838737 THE OB-C GROUP, LLC f798747a-832d-48a7-8496-f73df534d49d Q3 THE OB-C GROUP, LLC 29802 ELI LILLY 2009 third_quarter PHA HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-10-19T14:59:33-04:00
838796 MCDERMOTT WILL & SCHULTE LLP 9db45229-c844-4c16-8444-3c2298139139 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2009 third_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-19T15:03:51-04:00
838853 VAN NESS FELDMAN, LLP b4ceab4d-d4d0-4c83-8d28-0f2b130c04ab Q3 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2009 third_quarter PHA H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-10-19T15:06:23-04:00
838870 AMERICAN PHARMACISTS ASSOCIATION 98366d13-ebfd-4162-ac71-86b20ca44c9c Q3 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2009 third_quarter PHA HR1204 - The Community Pharmacy Fairness Act of 2009 S80 - Pharmaceutical Market Access Act of 2009 HR1298/S525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR163 - Prescription Drug Affordability Act HR2400 - Strategies to Address Antimicrobial Resistance Act HR1706 - Protecting Consumer Access to Generic Drugs Act of 2009 HR3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all Pharmacy-Based Communications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting on the types of communications that patients receive at the pharmacy includes: medication guides; patients package inserts; and consumer medication information (Docket Number FDA2009D0181) Draft Guidance for Industry on Label Comprehension Studies for Nonprescription Drug Products;Availability (Docket Number FDA2009N0295) Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop (Docket Number FDA1977N0013) (formerly Docket No. 1977N0094L) Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph (Docket Number FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number FDA2006N0238) (formerly Docket No. 2006N0062) Expanded Access to Investigational Drugs for Treatment Use (Docket Number FDA2006N0237) (formerly Docket No. 2006N0061) Charging for Investigational Drugs Under an Investigational New Drug Application (Docket Number FDA2009N0247) Food and Drug Administration Transparency Task Force; Reopening of Comment Period (Docket Number DEA321a) Identification of Institution-based Individual Practitioners (Docket Number FDA2009N0374) Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments (Docket Number FDA2009N0441) Promotio… Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,SENATE,White House Office   157696 0 0 2009-10-19T15:08:10-04:00
838920 MCDERMOTT WILL & SCHULTE LLP 84d90496-b341-4dcd-ad43-bbd0b35122b7 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2009 third_quarter PHA Issues related to Section 340B of the Public Health Service Act. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-10-19T15:12:26-04:00
838950 SANOFI US SERVICES INC. f684f31b-db82-4ae1-8d68-de29d0c1c872 Q3 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2009 third_quarter PHA Issues related to the final regulations implementing those provisions of HR4896 "National Defense Authorization Act for FY2008" related to TRICARE retail pharmacy sales. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   1470000 0 0 2009-10-19T15:15:39-04:00
839731 AKIN GUMP STRAUSS HAUER & FELD a0352e16-348b-46a8-9804-da44451e3dc2 Q3 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2009 third_quarter PHA Promoting consumer benefits of authorized generic drugs Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-10-19T16:02:05-04:00
839734 ANIMAL HEALTH INSTITUTE e18360d0-a3c8-4c2b-8dcb-bf859c8b8233 Q3 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2009 third_quarter PHA Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, FDA Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; Affordable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2009-10-19T16:02:06-04:00
839943 WALMART INC. 8497413f-6c3a-4174-970d-136f4c6fd377 Q3 WALMART INC. 40305 WALMART INC 2009 third_quarter PHA H.R. 1548 & S. 1427 - to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes - Average Manufacturer's Price H.R. 616 & S. 511 - to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 - to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacists from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Council of Economic Advisers (CEA),Energy, Dept of,Environmental Protection Agency (EPA),Federal Energy Regulatory Commission (FERC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   1620000 0 0 2009-10-19T16:18:32-04:00
840032 UNIVERSITY OF IOWA cfa739d1-6993-4afc-8839-33b982c587e3 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2009 third_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY2009 and FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2009-10-19T16:24:01-04:00
840367 TARPLIN, DOWNS & YOUNG, LLC 12c48437-3dc4-4ad3-8a98-afdfd11e66eb Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2009 third_quarter PHA **see addendum page Importation of prescription drugs (S. 525/H.R. 1298/S. 1232) RX Pedigree Pharmacy Accreditation Delay (H.R. 3663) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-19T16:47:18-04:00
840794 WALGREEN COMPANY b84191fc-09ed-414f-91a8-5ebc32d3d664 Q3 WALGREEN COMPANY 309071 WALGREEN COMPANY 2009 third_quarter PHA S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the TRICARE Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for TRICAREe beneficiaries. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE   370000 0 0 2009-10-19T17:18:43-04:00
841223 PRICEWATERHOUSECOOPERS 2204b36f-c035-4258-9db4-f9078d272743 Q3 PRICEWATERHOUSECOOPERS 10764 SCHERING-PLOUGH CORPORATION 2009 third_quarter PHA General issues affecting pharmaceutical companies HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2009-10-19T17:44:28-04:00
841376 HERBERT ALLEN "MIKE" AILSWORTH ace90a18-4ef5-4825-b975-0ba32ab02381 Q3 HERBERT ALLEN "MIKE" AILSWORTH 290558 SANOFI-AVENTIS U S INC 2009 third_quarter PHA General issues affecting the Pharmaceutical Industry. HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2009-10-19T17:58:14-04:00
841932 THE MATHIS HARPLE GROUP 92f11e13-070e-4bc6-bf72-42aedd5ebd0e Q3 THE MATHIS HARPLE GROUP 322911 PILMA 2009 third_quarter PHA Patent issues on Biologics HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-10-19T19:10:57-04:00
841962 WINSTON & STRAWN LLP 8b791f08-0912-43ab-8342-78f1475ca1bf Q3 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2009 third_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and vancomycin. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-19T19:17:02-04:00
842027 HILL PARTNER, LLC 5c107dd3-f923-463e-a436-fcb07dd8528b Q3 HILL PARTNER, LLC 317652 S&S TECHNOLOGY 2009 third_quarter PHA Protection of the United States Prescription Drug Supply Chain from counterfeiters and mishandling during shipments Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-19T19:26:20-04:00
842270 WINSTON & STRAWN LLP ddb2cb60-22ad-4789-98bf-9a1cd4ff744f Q3 WINSTON & STRAWN LLP 41682 ABRAXIS BIOSCIENCE LLC 2009 third_quarter PHA Issues related to safety of breast cancer drugs HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-19T20:15:26-04:00
843091 THE RUSSELL GROUP, INC. 4b7ff037-a011-4423-9ce2-bf8f22ff9193 Q3 THE RUSSELL GROUP, INC. 22688 GENERIC PHARMACEUTICAL ASSOCIATION 2009 third_quarter PHA Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-10-20T09:14:25-04:00
843199 SUPERVALU INC. 9f974002-529e-4efe-bd82-64f8c14201c6 Q3 SUPERVALU INC. 400275287 SUPERVALU INC 2009 third_quarter PHA Proposed legislation regarding pharmacy reimbursements. HOUSE OF REPRESENTATIVES,SENATE   180000 0 0 2009-10-20T09:19:21-04:00
843331 ACADEMY OF MANAGED CARE PHARMACY 2fda0b20-76df-4186-bf97-3850ee4ef183 Q3 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2009 third_quarter PHA Health care reform with respect to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally. HOUSE OF REPRESENTATIVES,SENATE   169000 0 0 2009-10-20T09:33:37-04:00
843424 BLUECROSS BLUESHIELD OF TENNESSEE 5abc358d-39a5-463d-919a-56f5fc2b7f7f Q3 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2009 third_quarter PHA Biologicals S. 623 E-Prescribing - Enhanced Health Care Value for All Act Comparative Effectiveness Research Act HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2009-10-20T09:40:54-04:00
843661 APOTEX CORP. e86c173c-11c0-4890-bfb1-0c0ac33ac481 Q3 APOTEX CORP. 310973 APOTEX CORP. 2009 third_quarter PHA S. 369, the Preserve Access to Affordable Pharmaceuticals Act HR 1706, the Protecting Consumer Access to Generic Drugs Act S. 1315, the Drug Price Competition Act of 2009 HR 3200, Subtitle C - Food & Drug Administration, Section 2563, Protecting Consumer Access to Generic Drugs HR 3200, Subtitle C, Food & Drug Administration, Part 2, Biosimilars Section 2565, Licensure Pathway for Biosimilar Biological Products HR 1427, the Promoting Innovation and Access to Life Savings Medicine Act HR 1548, Pathway for Biosimilars Act Congressional Budget Office (CBO),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2009-10-20T09:59:27-04:00
843849 NOVO NORDISK INC. f9c95eea-6e3c-4d54-8697-aa538af6ace6 Q3 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2009 third_quarter PHA H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE   430000 0 0 2009-10-20T10:08:21-04:00
844014 ROETZEL & ANDRESS, LPA fb6c4a15-6bae-472e-8b7f-f3baabb52af9 Q3 ROETZEL & ANDRESS, LPA 304452 LILLY USA 2009 third_quarter PHA matters pertaining to pharmacy matters HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-20T10:15:32-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2064.535ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API